Integra LifeSciences Shares Owned By Institutions vs. Net Income
| IART Stock | USD 24.24 0.66 2.80% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.5 | 0.5763 |
|
|
For Integra LifeSciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Integra LifeSciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Integra LifeSciences Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Integra LifeSciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Integra LifeSciences Holdings over time as well as its relative position and ranking within its peers.
Integra |
Integra LifeSciences' Revenue Breakdown by Earning Segment
Check out Risk vs Return Analysis.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Integra LifeSciences. If investors know Integra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Integra LifeSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.60) | Earnings Share (0.09) | Revenue Per Share 20.23 | Quarterly Revenue Growth (0) | Return On Assets 0.0302 |
The market value of Integra LifeSciences is measured differently than its book value, which is the value of Integra that is recorded on the company's balance sheet. Investors also form their own opinion of Integra LifeSciences' value that differs from its market value or its book value, called intrinsic value, which is Integra LifeSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Integra LifeSciences' market value can be influenced by many factors that don't directly affect Integra LifeSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Integra LifeSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Integra LifeSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Integra LifeSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Integra LifeSciences Net Income vs. Shares Owned By Institutions Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Integra LifeSciences's current stock value. Our valuation model uses many indicators to compare Integra LifeSciences value to that of its competitors to determine the firm's financial worth. Integra LifeSciences Holdings is rated fifth overall in shares owned by institutions category among its peers. It is rated third overall in net income category among its peers making up about 726,289 of Net Income per Shares Owned By Institutions. At this time, Integra LifeSciences' Net Income is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Integra LifeSciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Integra Net Income vs. Shares Owned By Institutions
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Integra LifeSciences |
| = | 93.27 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Integra LifeSciences |
| = | 67.74 M |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Integra Net Income Comparison
Integra LifeSciences is currently under evaluation in net income category among its peers.
Integra LifeSciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Integra LifeSciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Integra LifeSciences will eventually generate negative long term returns. The profitability progress is the general direction of Integra LifeSciences' change in net profit over the period of time. It can combine multiple indicators of Integra LifeSciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -15.1 M | -15.9 M | |
| Operating Income | 111.5 M | 70.7 M | |
| Income Before Tax | 81.1 M | 51.6 M | |
| Total Other Income Expense Net | -30.5 M | -28.9 M | |
| Net Income | 67.7 M | 44.5 M | |
| Income Tax Expense | 13.3 M | 7.6 M | |
| Net Income Applicable To Common Shares | 207.6 M | 218 M | |
| Net Income From Continuing Ops | 67.7 M | 75.5 M | |
| Non Operating Income Net Other | 28.3 M | 29.7 M | |
| Interest Income | 17.2 M | 10.1 M | |
| Net Interest Income | -34.2 M | -35.9 M | |
| Change To Netincome | 2.5 M | 2.4 M | |
| Net Income Per Share | 0.87 | 0.91 | |
| Income Quality | 2.07 | 1.62 | |
| Net Income Per E B T | 0.84 | 0.84 |
Integra Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Integra LifeSciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Integra LifeSciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Integra LifeSciences' important profitability drivers and their relationship over time.
Use Integra LifeSciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Integra LifeSciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integra LifeSciences will appreciate offsetting losses from the drop in the long position's value.Integra LifeSciences Pair Trading
Integra LifeSciences Holdings Pair Trading Analysis
The ability to find closely correlated positions to Integra LifeSciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Integra LifeSciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Integra LifeSciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Integra LifeSciences Holdings to buy it.
The correlation of Integra LifeSciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Integra LifeSciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Integra LifeSciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Integra LifeSciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Integra LifeSciences position
In addition to having Integra LifeSciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cannabis Thematic Idea Now
Cannabis
Equities that are involved in production and delivery of legal cannabis. This theme is designed for investors that are willing to accept higher levels of market risk inherited by cannabis production and distribution globally. The Cannabis theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cannabis Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Integra Stock Analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.